Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

July 01, 2011; Volume 338,Issue 1

Highlighted Papers

  • You have access
    MDM2 Knockdown Requires Wild-Type p53 Expression to Inhibit Prostate Cancer Growth
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 1;
  • You have access
    Natural Variations in Human Cholinesterase Genes Associated with Cardiovascular Disease
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 1;
  • You have access
    Estrogen Receptor Independent Effects of Tamoxifen
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 1;
  • You have access
    Tramadol and Abuse Liability in Humans
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 1;

Behavioral Pharmacology

  • You have access
    Preclinical Pharmacology of AZD2327: A Highly Selective Agonist of the δ-Opioid Receptor
    T. J. Hudzik, C. Maciag, M. A. Smith, R. Caccese, M. R. Pietras, K. H. Bui, M. Coupal, L. Adam, K. Payza, A. Griffin, G. Smagin, D. Song, M. D. B. Swedberg and W. Brown
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 195-204; DOI: https://doi.org/10.1124/jpet.111.179432
  • You have access
    Discriminative Stimulus Effects of Tramadol in Humans
    Angela N. Duke, George E. Bigelow, Ryan K. Lanier and Eric C. Strain
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 255-262; DOI: https://doi.org/10.1124/jpet.111.181131

Cardiovascular

  • You have access
    Celecoxib and 2,5-Dimethyl-Celecoxib Prevent Cardiac Remodeling Inhibiting Akt-Mediated Signal Transduction in an Inherited Dilated Cardiomyopathy Mouse Model
    Xueli Fan, Fumi Takahashi-Yanaga, Sachio Morimoto, Dong-Yun Zhan, Kazunobu Igawa, Katsuhiko Tomooka and Toshiyuki Sasaguri
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 2-11; DOI: https://doi.org/10.1124/jpet.111.179325
  • You have access
    Thienopyridines, but Not Elinogrel, Result in Off-Target Effects at the Vessel Wall That Contribute to Bleeding
    Patrick André, Francis DeGuzman, Helena Haberstock-Debic, Scott Mills, Yvonne Pak, Mayuko Inagaki, Anjali Pandey, Stanley Hollenbach, David R. Phillips and Pamela B. Conley
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 22-30; DOI: https://doi.org/10.1124/jpet.110.178574
  • You have access
    Catalase and Superoxide Dismutase Conjugated with Platelet-Endothelial Cell Adhesion Molecule Antibody Distinctly Alleviate Abnormal Endothelial Permeability Caused by Exogenous Reactive Oxygen Species and Vascular Endothelial Growth Factor
    Jingyan Han, Vladimir V. Shuvaev and Vladimir R. Muzykantov
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 82-91; DOI: https://doi.org/10.1124/jpet.111.180620
  • You have access
    The Bulky N(6) Substituent of Cabergoline Is Responsible for Agonism of This Drug at 5-Hydroxytryptamine (5-HT)2A and 5-HT2B Receptors and Thus Is a Determinant of Valvular Heart Disease
    Alexandra Kekewska, Harald Hübner, Peter Gmeiner and Heinz H. Pertz
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 381-391; DOI: https://doi.org/10.1124/jpet.111.181255

Cellular and Molecular

  • You have access
    Regulation of κ-Opioid Receptor Signaling in Peripheral Sensory Neurons In Vitro and In Vivo
    Kelly A. Berg, Matthew P. Rowan, Teresa A. Sanchez, Michelle Silva, Amol M. Patwardhan, Stephen B. Milam, Kenneth M. Hargreaves and William P. Clarke
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 92-99; DOI: https://doi.org/10.1124/jpet.110.177493
  • You have access
    Identification and Characterization of INCB9471, an Allosteric Noncompetitive Small-Molecule Antagonist of C-C Chemokine Receptor 5 with Potent Inhibitory Activity against Monocyte Migration and HIV-1 Infection
    Niu Shin, Kim Solomon, Naiming Zhou, Kathy He Wang, Vasudha Garlapati, Beth Thomas, Yanlong Li, Maryanne Covington, Frederic Baribaud, Susan Erickson-Viitanen, Phil Czerniak, Nancy Contel, Phillip Liu, Timothy Burn, Gregory Hollis, Swamy Yeleswaram, Kris Vaddi, Chu-Biao Xue, Brian Metcalf, Steve Friedman, Peggy Scherle and Robert Newton
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 228-239; DOI: https://doi.org/10.1124/jpet.111.179531
  • You have access
    The Ligands of Estrogen Receptor α Regulate Cytochrome P4502C9 (CYP2C9) Expression
    Jessica Mwinyi, Isa Cavaco, Begum Yurdakok, Souren Mkrtchian and Magnus Ingelman-Sundberg
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 302-309; DOI: https://doi.org/10.1124/jpet.110.175075
  • You have access
    Identification of a High-Affinity Ligand That Exhibits Complete Aryl Hydrocarbon Receptor Antagonism
    Kayla J. Smith, Iain A. Murray, Rachel Tanos, John Tellew, Anthony E. Boitano, William H. Bisson, Siva K. Kolluri, Michael P. Cooke and Gary H. Perdew
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 318-327; DOI: https://doi.org/10.1124/jpet.110.178392

Chemotherapy, Antibiotics, and Gene Therapy

  • You have access
    Rapamycin Inhibits Formation of Urethral Stricture in Rabbits
    Tie Chong, De-lai Fu, He-cheng Li, Hui-bo Zhang, Peng Zhang, Wei-min Gan and Zi-ming Wang
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 47-52; DOI: https://doi.org/10.1124/jpet.110.178624
  • You have access
    Synergistic Suppression of Prostatic Cancer Cells by Coexpression of Both Murine Double Minute 2 Small Interfering RNA and Wild-Type p53 Gene In Vitro and In Vivo
    Kun Ji, Bo Wang, Yue-ting Shao, Ling Zhang, Ya-nan Liu, Chen Shao, Xiao-jie Li, Xin Li, Jia-di Hu, Xue-jian Zhao, De-qi Xu, Yang Li and Lu Cai
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 173-183; DOI: https://doi.org/10.1124/jpet.111.180364

Drug Discovery and Translational Medicine

  • You have access
    A Method to Quantify Illicit Intake of Drugs from Urine: Methamphetamine
    Linghui Li, Gantt P. Galloway, Davide Verotta, E. Thomas Everhart, Matthew J. Baggott, Jeremy R. Coyle, Juan C. Lopez and John Mendelson
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 31-36; DOI: https://doi.org/10.1124/jpet.111.179176
  • You have access
    Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
    Kay Ahn, Sarah E. Smith, Marya B. Liimatta, David Beidler, Nalini Sadagopan, David T. Dudley, Tim Young, Paul Wren, Yanhua Zhang, Steven Swaney, Keri Van Becelaere, Jacqueline L. Blankman, Daniel K. Nomura, Shobha N. Bhattachar, Cory Stiff, Tyzoon K. Nomanbhoy, Eranthie Weerapana, Douglas S. Johnson and Benjamin F. Cravatt
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 114-124; DOI: https://doi.org/10.1124/jpet.111.180257
  • You have access
    ABT-869, a Multitargeted Receptor Tyrosine Kinase Inhibitor, Reduces Tumor Microvascularity and Improves Vascular Wall Integrity in Preclinical Tumor Models
    Fang Jiang, Daniel H. Albert, Yanping Luo, Paul Tapang, Ke Zhang, Steven K. Davidsen, Gerard B. Fox, Richard Lesniewski and Evelyn M. McKeegan
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 134-142; DOI: https://doi.org/10.1124/jpet.110.178061
  • You have access
    The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise?
    Stacey J. Sukoff Rizzo, Sarah K. Leonard, Adam Gilbert, Paul Dollings, Deborah L. Smith, Mei-Yi Zhang, Li Di, Brian J. Platt, Sarah Neal, Jason M. Dwyer, Corey N. Bender, Jean Zhang, Tim Lock, Dianne Kowal, Angela Kramer, Andrew Randall, Christine Huselton, Karthick Vishwanathan, Susanna Y. Tse, John Butera, Robert H. Ring, Sharon Rosenzweig-Lipson, Zoë A. Hughes and John Dunlop
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 345-352; DOI: https://doi.org/10.1124/jpet.110.177378

Endocrine and Diabetes

  • You have access
    Pharmacological Targeting of Glucagon and Glucagon-Like Peptide 1 Receptors Has Different Effects on Energy State and Glucose Homeostasis in Diet-Induced Obese Mice
    Wei Gu, David J. Lloyd, Narumol Chinookswong, Renée Komorowski, Glenn Sivits, Melissa Graham, Katherine A. Winters, Hai Yan, Laszlo G. Boros, Richard A. Lindberg and Murielle M. Véniant
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 70-81; DOI: https://doi.org/10.1124/jpet.111.179986
  • You have access
    Tamoxifen Regulation of Bone Growth and Endocrine Function in the Ovariectomized Rat: Discrimination of Responses Involving Estrogen Receptor α/Estrogen Receptor β, G Protein-Coupled Estrogen Receptor, or Estrogen-Related Receptor γ Using Fulvestrant (ICI 182780)
    James M. Fitts, Robert M. Klein and C. Andrew Powers
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 246-254; DOI: https://doi.org/10.1124/jpet.110.173955

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • You have access
    Increased Activation of the Wnt/β-Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout Mice
    Andy Wolfe, Ann Thomas, Genea Edwards, Reshma Jaseja, Grace L. Guo and Udayan Apte
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 12-21; DOI: https://doi.org/10.1124/jpet.111.179390
  • You have access
    Pharmacologic Specificity of Nicotinic Receptor-Mediated Relaxation of Muscarinic Receptor Precontracted Human Gastric Clasp and Sling Muscle Fibers within the Gastroesophageal Junction
    Alan S. Braverman, Anil K. Vegesna, Larry S. Miller, Mary F. Barbe, Mansoor Tiwana, Kashif Hussain and Michael R. Ruggieri
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 37-46; DOI: https://doi.org/10.1124/jpet.110.177097
  • You have access
    Retinol-Binding Protein 4 and Peroxisome Proliferator-Activated Receptor-γ in Steatotic Liver Transplantation
    Araní Casillas-Ramírez, Izabel Alfany-Fernández, Marta Massip-Salcedo, M. Emília Juan, Joana M. Planas, Anna Serafín, Mercè Pallàs, Antoni Rimola, Juan Rodés and Carmen Peralta
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 143-153; DOI: https://doi.org/10.1124/jpet.110.177691
  • You have access
    Comparative Analysis of the Effects of Antimuscarinic Agents on Bladder Functions in Both Nonhuman Primates and Rodents
    Hiroshi Nagabukuro, Katherine L. Villa, L. Alexandra Wickham, Alison A. Kulick, Loise Gichuru, Marcie J. Donnelly, Gregory O. Voronin, Tony Pereira, Xinchun Tong, Andrew Nichols, Stephen E. Alves, Gary P. O'Neill, Christopher V. Johnson and Emily J. Hickey
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 220-227; DOI: https://doi.org/10.1124/jpet.111.179747
  • You have access
    Distinct Actions of Endothelin A-Selective Versus Combined Endothelin A/B Receptor Antagonists in Early Diabetic Kidney Disease
    Mohamed A. Saleh, Jennifer S. Pollock and David M. Pollock
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 263-270; DOI: https://doi.org/10.1124/jpet.111.178988
  • You have access
    Rho Kinase Inhibition by Fasudil Attenuates Cyclosporine-Induced Kidney Injury
    Jeong Woo Park, Cheon Hoon Park, In Jin Kim, Eun Hui Bae, Seong Kwon Ma, Jong Un Lee and Soo Wan Kim
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 271-279; DOI: https://doi.org/10.1124/jpet.111.179457
  • You have access
    JNJ-26070109 [(R)4-Bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: A Novel, Potent, and Selective Cholecystokinin 2 Receptor Antagonist with Good Oral Bioavailability
    Magda F. Morton, Terrance D. Barrett, Jamie Freedman, Lina Li, Michele C. Rizzolio, Clodagh E. Prendergast, Xiaodong Wu, Veronica Moreno, Jayashree Pyati, Katherine Figueroa, Laurence Cagnon, Guy Lagaud, Luc Ver Donck, Etienne Ghoos, Brett Allison, Michael H. Rabinowitz and Nigel P. Shankley
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 328-336; DOI: https://doi.org/10.1124/jpet.110.178483
  • You have access
    Rapid, Nongenomic Stimulation of Multidrug Resistance Protein 2 (Mrp2) Activity by Glucocorticoids in Renal Proximal Tubule
    Brigitte Prevoo, David S. Miller, Femke M. van de Water, Kimberley E. Wever, Frans G. M. Russel, Gert Flik and Rosalinde Masereeuw
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 362-371; DOI: https://doi.org/10.1124/jpet.111.179689
  • You have access
    Enhanced Sensitivity to Afferent Stimulation and Impact of Overactive Bladder Therapies in the Conscious, Spontaneously Hypertensive Rat
    Phani B. Patra and Kevin S. Thorneloe
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 392-399; DOI: https://doi.org/10.1124/jpet.111.180885
  • You have access
    Type 1 Diabetes-Induced Hyper-Responsiveness to 5-Hydroxytryptamine in Rat Pulmonary Arteries via Oxidative Stress and Induction of Cyclooxygenase-2
    Jose G. Lopez-Lopez, Javier Moral-Sanz, Giovanna Frazziano, Maria J. Gomez-Villalobos, Laura Moreno, Carmen Menendez, Jorge Flores-Hernandez, Jose A. Lorente, Angel Cogolludo and Francisco Perez-Vizcaino
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 400-407; DOI: https://doi.org/10.1124/jpet.111.179515

Inflammation, Immunopharmacology, and Asthma

  • You have access
    Antiarthritis Effect of a Novel Bruton's Tyrosine Kinase (BTK) Inhibitor in Rat Collagen-Induced Arthritis and Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling: Relationships between Inhibition of BTK Phosphorylation and Efficacy
    Lichuan Liu, Julie Di Paolo, Jim Barbosa, Hong Rong, Karin Reif and Harvey Wong
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 154-163; DOI: https://doi.org/10.1124/jpet.111.181545
  • You have access
    Cinnamyl-3,4-Dihydroxy-α-Cyanocinnamate Is a Potent Inhibitor of 5-Lipoxygenase
    Carlo Pergola, Bianca Jazzar, Antonietta Rossi, Ulrike Buehring, Susann Luderer, Friederike Dehm, Hinnak Northoff, Lidia Sautebin and Oliver Werz
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 205-213; DOI: https://doi.org/10.1124/jpet.111.180794
  • You have access
    Pharmacology of AM211, a Potent and Selective Prostaglandin D2 Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation
    Gretchen Bain, Daniel S. Lorrain, Karin J. Stebbins, Alex R. Broadhead, Angelina M. Santini, Pat Prodanovich, Janice Darlington, Christopher D. King, Catherine Lee, Christopher Baccei, Brian Stearns, Yen Troung, John H. Hutchinson, Peppi Prasit and Jilly F. Evans
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 290-301; DOI: https://doi.org/10.1124/jpet.111.180430

Metabolism, Transport, and Pharmacogenomics

  • You have access
    Naturally Occurring Variations in the Human Cholinesterase Genes: Heritability and Association with Cardiovascular and Metabolic Traits
    Anne M. Valle, Zoran Radić, Brinda K. Rana, Vafa Mahboubi, Jennifer Wessel, Pei-an Betty Shih, Fangwen Rao, Daniel T. O'Connor and Palmer Taylor
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 125-133; DOI: https://doi.org/10.1124/jpet.111.180091
  • You have access
    Metabolism and Disposition of 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Baboons after Oral Administration: Comparison with Humans Reveals Marked Differences
    Melanie Mueller, Amy K. Goodwin, Nancy A. Ator, Una D. McCann and George A. Ricaurte
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 310-317; DOI: https://doi.org/10.1124/jpet.111.180612
  • You have access
    In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban
    Mark Jean Gnoth, Ulf Buetehorn, Uwe Muenster, Thomas Schwarz and Steffen Sandmann
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 372-380; DOI: https://doi.org/10.1124/jpet.111.180240

Neuropharmacology

  • You have access
    The Efficacy of Sodium Channel Blockers to Prevent Phencyclidine-Induced Cognitive Dysfunction in the Rat: Potential for Novel Treatments for Schizophrenia
    Charles H. Large, Silvia Bison, Ilaria Sartori, Kevin D. Read, Alessandro Gozzi, Davide Quarta, Marinella Antolini, Emma Hollands, Catherine H. Gill, Martin J. Gunthorpe, Nagi Idris, Jo C. Neill and Giuseppe S. Alvaro
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 100-113; DOI: https://doi.org/10.1124/jpet.110.178475
  • You have access
    Haloperidol Disrupts Opioid-Antinociceptive Tolerance and Physical Dependence
    Cheng Yang, Yan Chen, Lei Tang and Zaijie Jim Wang
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 164-172; DOI: https://doi.org/10.1124/jpet.110.175539
  • You have access
    Selective GABA Transporter Inhibitors Tiagabine and EF1502 Exhibit Mechanistic Differences in Their Ability to Modulate the Ataxia and Anticonvulsant Action of the Extrasynaptic GABAA Receptor Agonist Gaboxadol
    Karsten K. Madsen, Bjarke Ebert, Rasmus P. Clausen, Povl Krogsgaard-Larsen, Arne Schousboe and H. Steve White
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 214-219; DOI: https://doi.org/10.1124/jpet.111.179671
  • You have access
    Amperometric Measurement of Glutamate Release Modulation by Gabapentin and Pregabalin in Rat Neocortical Slices: Role of Voltage-Sensitive Ca2+ α2δ-1 Subunit
    Jorge E. Quintero, David J. Dooley, François Pomerleau, Peter Huettl and Greg A. Gerhardt
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 240-245; DOI: https://doi.org/10.1124/jpet.110.178384
  • You have access
    Abuse Liability Profile of Three Substituted Tryptamines
    Michael B. Gatch, Michael J. Forster, Aaron Janowsky and Amy J. Eshleman
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 280-289; DOI: https://doi.org/10.1124/jpet.111.179705
  • You have access
    Fasudil and Ozagrel in Combination Show Neuroprotective Effects on Cerebral Infarction after Murine Middle Cerebral Artery Occlusion
    Akihiro Koumura, Junya Hamanaka, Koh Kawasaki, Kazuhiro Tsuruma, Masamitsu Shimazawa, Isao Hozumi, Takashi Inuzuka and Hideaki Hara
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 337-344; DOI: https://doi.org/10.1124/jpet.110.177675

Toxicology

  • You have access
    Cerium Oxide Nanoparticles Inhibits Oxidative Stress and Nuclear Factor-κB Activation in H9c2 Cardiomyocytes Exposed to Cigarette Smoke Extract
    Jianli Niu, Kangkai Wang and Pappachan E. Kolattukudy
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 53-61; DOI: https://doi.org/10.1124/jpet.111.179978
  • You have access
    Inhibition of Rab1 GTPase and Endoplasmic Reticulum-to-Golgi Trafficking Underlies Statin's Toxicity in Rat Skeletal Myofibers
    Kazuho Sakamoto, Ikuo Wada and Junko Kimura
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 62-69; DOI: https://doi.org/10.1124/jpet.111.179762
  • You have access
    Up-Regulation of Extracellular Signal-Regulated Kinase 1/2-Dependent Thymidylate Synthase and Thymidine Phosphorylase Contributes to Cisplatin Resistance in Human Non–Small-Cell Lung Cancer Cells
    Jen-Chung Ko, Min-Shao Tsai, Yu-Fan Chiu, Shao-Hsing Weng, Ya-Hsun Kuo and Yun-Wei Lin
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 184-194; DOI: https://doi.org/10.1124/jpet.111.179663
  • You have access
    Metabolism of [D10]Phenanthrene to Tetraols in Smokers for Potential Lung Cancer Susceptibility Assessment: Comparison of Oral and Inhalation Routes of Administration
    Yan Zhong, Jing Wang, Steven G. Carmella, J. Bradley Hochalter, Diane Rauch, Andrew Oliver, Joni Jensen, Dorothy K. Hatsukami, Pramod Upadhyaya, Cheryl Zimmerman and Stephen S. Hecht
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 353-361; DOI: https://doi.org/10.1124/jpet.111.181719

Errata

  • You have access
    Correction to “Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2”
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 408-409;
  • You have access
    Correction to “N-((1S)-1-{[4-((2S)-2-{[2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a Novel and Potent Transient Receptor Potential Vanilloid 4 Channel Agonist Induces Urinary Bladder Contraction and Hyperactivity: Part I”
    Journal of Pharmacology and Experimental Therapeutics July 2011, 338 (1) 410;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 338 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 338, Issue 1
1 Jul 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Highlighted Papers
  • Behavioral Pharmacology
  • Cardiovascular
  • Cellular and Molecular
  • Chemotherapy, Antibiotics, and Gene Therapy
  • Drug Discovery and Translational Medicine
  • Endocrine and Diabetes
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Toxicology
  • Errata
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics